BR0302819A - Peptìdeos sintéticos que exibem atividade inibidora contra invasão de câncer e metástases - Google Patents

Peptìdeos sintéticos que exibem atividade inibidora contra invasão de câncer e metástases

Info

Publication number
BR0302819A
BR0302819A BR0302819-4A BR0302819A BR0302819A BR 0302819 A BR0302819 A BR 0302819A BR 0302819 A BR0302819 A BR 0302819A BR 0302819 A BR0302819 A BR 0302819A
Authority
BR
Brazil
Prior art keywords
metastasis
cancer invasion
inhibitory activity
activity against
synthetic peptides
Prior art date
Application number
BR0302819-4A
Other languages
English (en)
Inventor
Matthias Rath
Shrirang Netke
Aleksandra Niedzwiecki
Original Assignee
Matthias Rath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matthias Rath filed Critical Matthias Rath
Publication of BR0302819A publication Critical patent/BR0302819A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PEPTìDEOS SINTéTICOS QUE EXIBEM ATIVIDADE INIBIDORA CONTRA INVASãO DE CâNCER E METáSTASES". A presente invenção se relaciona a peptídeos sintéticos que exibem atividade inibidora contra a invasão de câncer e metástases. Os peptídeos da invenção compreendem o peptídeo PRKPKWDK (ID. DE SEQ.:2) que corresponde aos aminoácidos de 85 a 92 da metaloproteinase da matriz (MMP-2), e fragmentos, análogos e homólogos da ID. DE SEQ. :2. A invenção também se relaciona aos usos de tais peptídeos como inibidores da invasão de câncer e metástases humanas e ainda ao seu uso terapêutico na prevenção e tratamento de câncer e outras condições patológicas relacionadas à degradação da matriz extracelular por MMPS.
BR0302819-4A 2002-01-23 2003-01-23 Peptìdeos sintéticos que exibem atividade inibidora contra invasão de câncer e metástases BR0302819A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35131702P 2002-01-23 2002-01-23
PCT/EP2003/000659 WO2003062413A1 (en) 2002-01-23 2003-01-23 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis

Publications (1)

Publication Number Publication Date
BR0302819A true BR0302819A (pt) 2004-04-27

Family

ID=27613485

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0302819-4A BR0302819A (pt) 2002-01-23 2003-01-23 Peptìdeos sintéticos que exibem atividade inibidora contra invasão de câncer e metástases

Country Status (22)

Country Link
US (1) US8012935B2 (pt)
EP (1) EP1468085B1 (pt)
JP (1) JP2005515262A (pt)
KR (1) KR20040077764A (pt)
CN (2) CN101007844A (pt)
AT (1) ATE425247T1 (pt)
BR (1) BR0302819A (pt)
CA (1) CA2472775A1 (pt)
DE (1) DE60326539D1 (pt)
EE (1) EE200400030A (pt)
ES (1) ES2324027T3 (pt)
HR (1) HRP20040732A2 (pt)
IL (1) IL162714A0 (pt)
LV (2) LV13289B (pt)
MX (1) MXPA04007170A (pt)
NO (1) NO20034146L (pt)
NZ (1) NZ533738A (pt)
PL (1) PL209827B1 (pt)
RU (1) RU2346043C2 (pt)
WO (1) WO2003062413A1 (pt)
YU (1) YU76403A (pt)
ZA (1) ZA200405328B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856598B1 (fr) * 2003-06-25 2005-10-28 Inst Nat Sante Rech Med Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale
JP4911950B2 (ja) * 2005-11-07 2012-04-04 晃 伊東 Ｍｍｐ−１の部分ペプチドを用いた癌浸潤・転移阻害薬
WO2010100282A1 (en) * 2009-03-06 2010-09-10 Universite Paris Descartes Method for treating cancer
US8593732B1 (en) * 2010-01-23 2013-11-26 Lightsmyth Technologies, Inc. Partially metallized total internal reflection immersion grating
US8003110B1 (en) * 2011-01-24 2011-08-23 Matthias W. Rath Metalloproteinase oligopeptides and their therapeutic use
EP2649985A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
US20140017267A1 (en) * 2012-07-13 2014-01-16 Matthias W Rath Metalloproteinase oligopeptides and their therapeutic use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
GB8817075D0 (en) * 1988-07-18 1988-08-24 Raychem Ltd Oscillation suppressor
US5646027A (en) * 1994-09-08 1997-07-08 Warner-Lambert Company Process for the production of gelatinase catalytic domain protein
EP2275553B1 (en) * 1999-10-29 2015-05-13 Novartis Vaccines and Diagnostics S.r.l. Neisserial antigenic peptides

Also Published As

Publication number Publication date
YU76403A (sh) 2006-05-25
PL371254A1 (en) 2005-06-13
LV13419B (en) 2006-09-20
ATE425247T1 (de) 2009-03-15
CA2472775A1 (en) 2003-07-31
WO2003062413A1 (en) 2003-07-31
JP2005515262A (ja) 2005-05-26
CN101007844A (zh) 2007-08-01
CN1622992A (zh) 2005-06-01
EP1468085B1 (en) 2009-03-11
RU2004125599A (ru) 2005-07-10
US20030139345A1 (en) 2003-07-24
ES2324027T3 (es) 2009-07-29
MXPA04007170A (es) 2004-10-29
DE60326539D1 (de) 2009-04-23
KR20040077764A (ko) 2004-09-06
EP1468085A1 (en) 2004-10-20
LV13289B (en) 2005-11-20
IL162714A0 (en) 2005-11-20
RU2346043C2 (ru) 2009-02-10
HRP20040732A2 (en) 2005-06-30
US8012935B2 (en) 2011-09-06
NO20034146L (no) 2003-10-28
EE200400030A (et) 2004-04-15
NO20034146D0 (no) 2003-09-17
ZA200405328B (en) 2006-03-29
PL209827B1 (pl) 2011-10-31
NZ533738A (en) 2006-03-31

Similar Documents

Publication Publication Date Title
MXPA04001033A (es) Compuesto de sanado para heridas y anti-cancer.
NO20041700L (no) Human koagulasjonsfaktor VII-polypeptider
AR039231A1 (es) Agentes de union ox40r novedosos
HRP20050585A2 (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
ITMI20021527A1 (it) Anticorpi anti componente c5 del complemento e loro uso
MX2008009493A (es) Peptido novedoso y uso del mismo.
MX2009008270A (es) Polipeptido novedoso que tiene actividad anti-tumoral.
FR2842209B1 (fr) Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
NZ596043A (en) Allergy inhibitor compositions and kits and methods of using the same
DE60138558D1 (de) Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung
NZ592911A (en) Leukolectins and uses thereof
EP4306123A3 (en) Saposin-a derived peptides and uses thereof
BR0302819A (pt) Peptìdeos sintéticos que exibem atividade inibidora contra invasão de câncer e metástases
RU2014134287A (ru) Бифункциональный пептид
BR0113147A (pt) Proteìnas e peptìdeos do estresse e métodos de uso dos mesmos
LT2004079A (en) Sythetic peptides and uses therof for the prevention and therapy of cancer invasion and metastasis
FR2858234B1 (fr) Nouvel agent anti-angiogenique et son utilisation, notamment dans le cadre du traitement des cancers
AR024472A1 (es) Inhibidores de la integrina alfav beta6.
ATE544779T1 (de) Neue, die migration dendritischer zellen induzierende polypeptide, sowie medikamente und pharmazeutische zusammensetzungen, die diese enthalten
WO2002053172A3 (en) Use of matrix metalloproteinase peptide substrate to lower the rate of extracellular matrix turnover
ATE417061T1 (de) Scorpionpeptid als blutdrucksenkendes mittel
Diamandis et al. Induction of Complement C3a Receptor
TH57872B (th) สารยับยั้งของอินทีกริน อัลฟานู เบตา6
DE50310131D1 (de) Peptide mit hohem cysteingehalt
AU2003205658A1 (en) Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A(S) 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2112 DE 28/06/2011.